Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 3
2021 6
2022 9
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
When Tissue is an Issue the Liquid Biopsy is Nonissue: A Review.
Rodríguez J, Avila J, Rolfo C, Ruíz-Patiño A, Russo A, Ricaurte L, Ordóñez-Reyes C, Arrieta O, Zatarain-Barrón ZL, Recondo G, Cardona AF. Rodríguez J, et al. Among authors: ordonez reyes c. Oncol Ther. 2021 Jun;9(1):89-110. doi: 10.1007/s40487-021-00144-6. Epub 2021 Mar 10. Oncol Ther. 2021. PMID: 33689160 Free PMC article. Review.
Integration of artificial intelligence and precision oncology in Latin America.
Sussman L, Garcia-Robledo JE, Ordóñez-Reyes C, Forero Y, Mosquera AF, Ruíz-Patiño A, Chamorro DF, Cardona AF. Sussman L, et al. Among authors: ordonez reyes c. Front Med Technol. 2022 Oct 13;4:1007822. doi: 10.3389/fmedt.2022.1007822. eCollection 2022. Front Med Technol. 2022. PMID: 36311461 Free PMC article. Review.
Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question.
Ordóñez-Reyes C, Garcia-Robledo JE, Chamorro DF, Mosquera A, Sussmann L, Ruiz-Patiño A, Arrieta O, Zatarain-Barrón L, Rojas L, Russo A, de Miguel-Perez D, Rolfo C, Cardona AF. Ordóñez-Reyes C, et al. Pharmaceutics. 2022 Jun 11;14(6):1243. doi: 10.3390/pharmaceutics14061243. Pharmaceutics. 2022. PMID: 35745815 Free PMC article. Review.
Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study.
Chamorro DF, Cardona AF, Rodríguez J, Ruiz-Patiño A, Arrieta O, Moreno-Pérez DA, Rojas L, Zatarain-Barrón ZL, Ardila DV, Viola L, Recondo G, Blaquier JB, Martín C, Raez L, Samtani S, Ordóñez-Reyes C, Garcia-Robledo JE, Corrales L, Sotelo C, Ricaurte L, Cuello M, Mejía S, Jaller E, Vargas C, Carranza H, Otero J, Archila P, Bermudez M, Gamez T, Russo A, Malapelle U, de Miguel Perez D, de Lima VCC, Freitas H, Saldahna E, Rolfo C, Rosell R; CLICaP. Chamorro DF, et al. Among authors: ordonez reyes c. Target Oncol. 2023 May;18(3):425-440. doi: 10.1007/s11523-023-00955-9. Epub 2023 Apr 5. Target Oncol. 2023. PMID: 37017806 Free PMC article.
DICER1-associated central nervous system sarcoma: A comprehensive clinical and genomic characterization of case series of young adult patients.
Cardona AF, Chamorro Ortiz DF, Ruíz-Patiño A, Gomez D, Muñoz Á, Ardila DV, Garcia-Robledo JE, Ordóñez-Reyes C, Sussmann L, Mosquera A, Forero Y, Rojas L, Hakim F, Jimenez E, Ramón JF, Cifuentes H, Pineda D, Mejía JA, Rodríguez J, Archila P, Sotelo C, Moreno-Pérez DA, Arrieta O. Cardona AF, et al. Among authors: ordonez reyes c. Neurooncol Pract. 2023 Mar 19;10(4):381-390. doi: 10.1093/nop/npad014. eCollection 2023 Aug. Neurooncol Pract. 2023. PMID: 37457227 Free PMC article.
Prognostic significance of telomerase reverse transcriptase promoter gen mutations in high grade meningiomas.
Cañas A, Jiménez E, Hakim F, Mejía JA, Ramón JF, Gómez D, Jaramillo-Velásquez D, Bermúdez S, Useche N, Pineda D, Cifuentes H, Becerra A, Muñoz Á, Santoyo N, Ruíz-Patiño A, Sotelo C, Archila P, Rodríguez J, Ávila J, Ordoñez-Reyes C, García-Robledo JE, Ricaurte L, Rojas L, Feo O, Burgos R, Ramírez C, Arrieta O, Zatarain-Barrón L, Vargas C, Carranza H, Otero J, Cardona AF. Cañas A, et al. Among authors: ordonez reyes c. Biomedica. 2022 Dec 1;42(4):574-590. doi: 10.7705/biomedica.6100. Biomedica. 2022. PMID: 36511679 Free PMC article. English, Spanish.
Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP).
Cardona AF, Ruiz-Patiño A, Recondo G, Martín C, Raez L, Samtani S, Minata JN, Blaquier JB, Enrico D, Burotto M, Ordóñez-Reyes C, Chamorro DF, Garcia-Robledo JE, Corrales L, Zatarain-Barrón ZL, Más L, Sotelo C, Ricaurte L, Santoyo N, Cuello M, Mejía S, Jaller E, Vargas C, Carranza H, Otero J, Rodríguez J, Archila P, Bermudez M, Gamez T, Cordeiro de Lima V, Freitas H, Russo A, Polo C, Malapelle U, Perez DM, Rolfo C, Viola L, Rosell R, Arrieta O. Cardona AF, et al. Among authors: ordonez reyes c. Clin Lung Cancer. 2022 Sep;23(6):522-531. doi: 10.1016/j.cllc.2022.06.001. Epub 2022 Jun 6. Clin Lung Cancer. 2022. PMID: 35798634
21 results